ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every product launch announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
9 announcements with these filters
Aayush Wellness launched Himalayan Shilajit Drops, entering the Shilajit supplement category. The company cites a USD 436.72 million global market by 2034 but discloses no sales figures.
TVS Motor launched the TVS Ronin and TVS NTORQ XP in Mauritius alongside a new distribution partnership with Le Warehouse and 361. No financial value was disclosed.
Bharat Forge's defence subsidiary KSSL unveiled the 120mm Rapid Attack Mortar System for Indian Armed Forces and international customers. No order value or contract was announced.
Lupin announced the European launch of its biosimilar Ranibizumab (Ranluspec) via commercial partner Sandoz. The launch covers Europe excluding Germany following European Commission approval.
LTM publishes AI-QEM, its Quantum Error Mitigation tool, in IBM's Quantum Functions Catalog, becoming the first global systems integrator to do so.
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.